Medirom Healthcare Technologies shares rise 2.02% intraday as MOTHER Labs subsidiary secures 9 billion yen funding for upgraded wearable device development.
ByAinvest
Thursday, Oct 9, 2025 11:37 am ET1min read
MRM--
Medirom Healthcare Technologies Inc. surged 2.02% intraday as its subsidiary MOTHER Labs announced approval for an internal financing round valued at 9 billion yen to develop an upgraded MOTHER Bracelet wearable device and its commercialization system. The company primarily operates in health services, including relaxation salons, digital preventive health, and luxury beauty, and drives health tech innovation and business expansion through its subsidiaries.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet